Shenzhen Kangtai Biological Products Co., Ltd.

Total Valuation

Shenzhen Kangtai Biological Products Co., Ltd. carries a market capitalization of 12.79B, placing it among publicly traded companies globally. Its enterprise value stands at 18.69B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Shenzhen Kangtai Biological Products Co., Ltd. currently has 1.12B shares outstanding.

Valuation Ratios

Shenzhen Kangtai Biological Products Co., Ltd. trades at a trailing price-to-earnings ratio of 230.72. The price-to-sales ratio is 6.00, and the price-to-book ratio stands at 5.28.

Enterprise Valuation

On an enterprise value basis, Shenzhen Kangtai Biological Products Co., Ltd. trades at an EV/EBITDA multiple of 52.56 and an EV/FCF ratio of 18.20. The EV/Sales ratio of 6.58 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 52.56 provides insight into valuation relative to core operating earnings.

Financial Position

Shenzhen Kangtai Biological Products Co., Ltd. maintains a current ratio of 2.66, meaning it holds 2.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 19.76, indicating elevated leverage, while an interest coverage ratio of 2.98 demonstrates limited ability to service its debt obligations.

Financial Efficiency

Taxes

Over the trailing twelve months, Shenzhen Kangtai Biological Products Co., Ltd. has paid -60.68M in income taxes, reflecting an effective tax rate of 23.09.

Stock Price Statistics

Shenzhen Kangtai Biological Products Co., Ltd.'s stock has declined approximately -24.22237% over the past 52 weeks. The 50-day moving average sits at 12.85, while the 200-day moving average is 14.81.

Income Statement

Over the trailing twelve months, Shenzhen Kangtai Biological Products Co., Ltd. generated 2.84B in revenue and converted that into 73.85M in net income, yielding earnings per share of 0.07. EBITDA reached 355.58M, while operating income came in at 355.58M.

Balance Sheet

Shenzhen Kangtai Biological Products Co., Ltd. holds 246.26M in cash and equivalents against 1.90B in total debt, resulting in a net debt position of 1.65B. Total book value stands at 3.23B, with working capital of 3.80B providing operational flexibility.

Cash Flow

After subtracting -355.74M in capital expenditures, free cash flow totaled -355.74M - equivalent to -0.32 per share.

Margins

Shenzhen Kangtai Biological Products Co., Ltd. operates with a gross margin of 78.28, reflecting its pricing power and cost economics. The operating margin of 12.51 and net profit margin of 2.60 provide insight into operational efficiency.

Dividends & Yields

The company's payout ratio of 171.05 indicates the proportion of earnings distributed to shareholders.

Stock Splits

Shenzhen Kangtai Biological Products Co., Ltd.'s most recent stock split took place on June 2, 2022 with a 5:8 split ratio.

Scores

Shenzhen Kangtai Biological Products Co., Ltd. posts an Altman Z-Score of 3.11, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.